CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
AMADIX develops innovative blood tests for early colorectal cancer detection using liquid biopsy technology. Their new test, PreveCol, aims to improve diagnostic accuracy by incorporating advanced biomarkers and artificial intelligence to identify individuals at high risk, enhancing early intervention and survival rate…
AMADIX is a leading molecular diagnostics company, led by Rocío Arroyo, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood.
Colorectal cancer (CRC) is the 2nd leading cause of cancer-related deaths worldwide.
Most of these cancers and deaths could have been prevented by increasing the use of recommended screening tests that detect premalignant lesions, called advanced adenomas.
Colonoscopy is the gold standard screening method, although it is an…
ADVANCED MARKER DISCOVERY SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
